Dupilumab Improves Health-Related Quality of Life in Omalizumab-Naïve Patients with Chronic Spontaneous Urticaria

Authors

Institutions

Publication Details

Journal
Dermatology and Therapy
Published
2025-12-02
DOI
https://doi.org/10.1007/s13555-025-01605-w
Primary Topic
Urticaria and Related Conditions
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Dupilumab Improves Health-Related Quality of Life in Omalizumab-Naïve Patients with Chronic Spontaneous Urticaria

Chien‐Chia Chuang, Allen R. Radin, Ryan B. Thomas, Sonya Cyr et al.
Dermatology and Therapy
Urticaria and Related Conditions
article

Dupilumab Improves Health-Related Quality of Life in Omalizumab-Naïve Patients with Chronic Spontaneous Urticaria

Chien‐Chia Chuang, Allen R. Radin, Ryan B. Thomas, Sonya Cyr, Luís Felipe Ensina, Jérôme Msihid, Ana Maria Giménez‐Arnau, Thomas B. Casale, Naoko Inomata, Gil Yosipovitch, Melanie Makhija, Philip B. Sugerman
article en

Abstract

No abstract available for this paper.
Dermatology and TherapyVol. 16(1)
SHOWA Medical University (JP), University of Miami (US), Universitat Pompeu Fabra (ES), Regeneron (United States) (US), University of South Florida (US), Sanofi (France) (FR), Sanofi (United States) (US), Universidade Federal de São Paulo (BR)
Sanofi, Regeneron Pharmaceuticals
Openalex Percentile: Top 46%
Urticaria and Related Conditions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.